Compositions for treating drug addiction and improving addiction-related behavior

Details for Australian Patent Application No. 2010263469 (hide)

Owner SK Biopharmaceuticals Co., Ltd.

Inventors Lee, Sung James; Melnick, Susan Marie

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010263469

PCT Pub. Number WO2010/150995

Priority 12/492,566 26.06.09 US

Filing date 10 June 2010

Wipo publication date 29 December 2010

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/223 (2006.01)

A61K 31/4965 (2006.01) - Non-condensed pyrazines

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/150995 Priority application(s): WO2010/150995

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010263478-Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids

2010263466-Bagasse composite, method for preparing same and interior material using same